Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: a case report within the experience of a single institution

Until recently, platinum-based chemotherapy has represented the benchmark for the treatment of extensive disease small-cell lung cancer (ED-SCLC). ED-SCLC patients are often diagnosed with poor performance status (PS ≥2) and/or compromised organ functions. In fact, up to 63% of ED-SCLC has extensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Federico, Alessandro, Andrini, Elisa, Sisi, Monia, Nuvola, Giacomo, Lamberti, Giuseppe, Lenzi, Barbara, Nobili, Elisabetta, Gelsomino, Francesco, Ardizzoni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911106/
https://www.ncbi.nlm.nih.gov/pubmed/33661187
http://dx.doi.org/10.1097/CAD.0000000000001057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911106/
https://www.ncbi.nlm.nih.gov/pubmed/33661187
http://dx.doi.org/10.1097/CAD.0000000000001057

Ejemplares similares